<DOC>
	<DOCNO>NCT00542711</DOCNO>
	<brief_summary>Curcumin commonly-used spice food coloring . Evidence suggest curcumin suppress tumor initiation , promotion metastasis variety tumor cell line . The current available curcumin low bioavailability restrict effect curcumin non-colon cancer . In study plan test new liquid tumeric/curcumin extract , Curcumol ( patent pending , Israel Patent Application No . 181,121 ) . We predict bioavailability liquid tumeric/curcumin extract well compare currently use curcumin powder .</brief_summary>
	<brief_title>Bio-availability New Liquid Tumeric Extract</brief_title>
	<detailed_description>Twelve healthy participant enrol study . All volunteer pre study evaluation confirm healthy state . After enrollment , participant test twice , one liquid tumeric/curcumin ( study drug ) curcumin powder ( control ) . The day test two day , separate two week wash-out period . The participant assign randomly receive study drug control 1st day , regimen administer 2nd day . Both study drug control dilute 150ml water . The doe study drug escalate 30 drop ( 4 participant ) , 50 drop ( 4 participant ) 70 drop ( 4 participant ) . Blood sample collect 0,0.25,0.5,0.75,1,2,3,4,5,6,8h post drug . Quantization curcumin plasma level do high pressure liquid chormatography method . A biomarker potential effect curcumin , platelet function pre post curcumin consumption test .</detailed_description>
	<mesh_term>Curcumin</mesh_term>
	<criteria>Complete Healthy Able attend two full day study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Curcumin</keyword>
	<keyword>Bioavilability</keyword>
	<keyword>Healthy subject</keyword>
</DOC>